CBT
MRK icon

CoreFirst Bank & Trust’s Merck MRK Stock Holding History

CoreFirst Bank & Trust’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
8,877
-25
-0.3% -$2.93K 0.57% 42
2026
Q1 		$1.07M Sell
8,902
-697
-7% -$80.5K 0.57% 41
2025
Q4 		$1.01M Sell
9,599
-499
-5% -$46.8K 0.55% 40
2025
Q3 		$848K Buy
10,098
+185
+2% +$15.2K 0.46% 47
2025
Q2 		$785K Hold
9,913
– – 0.44% 52
2025
Q1 		$890K Sell
9,913
-1,301
-12% -$121K 0.57% 43
2024
Q4 		$1.12M Sell
11,214
-381
-3% -$39.3K 0.66% 38
2024
Q3 		$1.32M Hold
11,595
– – 0.76% 31
2024
Q2 		$1.44M Sell
11,595
-162
-1% -$20.9K 0.97% 29
2024
Q1 		$1.55M Sell
11,757
-507
-4% -$62.5K 0.97% 29
2023
Q4 		$1.34M Sell
12,264
-265
-2% -$27.5K 0.89% 29
2023
Q3 		$1.29M Sell
12,529
-23
-0.2% -$2.48K 0.92% 26
2023
Q2 		$1.45M Sell
12,552
-841
-6% -$95.5K 1.02% 25
2023
Q1 		$1.42M Sell
13,393
-934
-7% -$101K 1.04% 25
2022
Q4 		$1.59M Sell
14,327
-36
-0.3% -$3.68K 1.21% 18
2022
Q3 		$1.24M Sell
14,363
-482
-3% -$43K 1.07% 22
2022
Q2 		$1.35M Buy
14,845
+1,024
+7% +$90.8K 1.07% 20
2022
Q1 		$1.13M Sell
13,821
-620
-4% -$48.9K 0.78% 28
2021
Q4 		$1.11M Sell
14,441
-190
-1% -$15.1K 0.72% 29
2021
Q3 		$1.1M Buy
14,631
+705
+5% +$53.6K 0.76% 29
2021
Q2 		$1.08M Sell
13,926
-668
-5% -$49.7K 0.74% 31
2021
Q1 		$1.07M Hold
14,594
– – 0.74% 29
2020
Q4 		$1.14M Buy
+14,594
New +$1.12M 0.84% 25

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CoreFirst Bank & Trust's MRK Position: Q2 2026 in Review

CoreFirst Bank & Trust reduced its Merck (MRK) stake by 0.28% in Q2 2026, selling an estimated $2.93K and leaving 8,877 shares worth $1.14M. The position accounts for 0.57% of the portfolio, ranked #42.

CoreFirst Bank & Trust first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.59M in Q4 2022. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CoreFirst Bank & Trust held 8,877 shares of Merck worth $1.14M as of Q2 2026.
  • CoreFirst Bank & Trust sold 25 Merck shares in Q2 2026, an estimated $2.93K.
  • Merck made up 0.57% of CoreFirst Bank & Trust's portfolio in Q2 2026, its #42 holding.
  • CoreFirst Bank & Trust first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • CoreFirst Bank & Trust's Merck position peaked at $1.59M in Q4 2022.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2026, filed 5 Aug 2026.